RXST Stock Performance, Insider Transaction and News

RXST - RxSight, Inc.

Market Cap	1.11B	P/E	-	EPS this Y	36.20%	Ern Qtrly Grth	-
Income	-48.61M	Forward P/E	-19.97	EPS next Y	21.10%	50D Avg Chg	15.00%
Sales	89.08M	PEG	-3.03	EPS past 5Y	-	200D Avg Chg	81.00%
Dividend	N/A	Price/Book	7.67	EPS next 5Y	19.00%	52W High Chg	-3.00%
Recommedations	1.50	Quick Ratio	7.06	Shares Outstanding	36.99M	52W Low Chg	235.00%
Insider Own	12.99%	ROA	-18.82%	Shares Float	27.81M	Beta	1.22
Inst Own	90.61%	ROE	-38.85%	Shares Shorted/Prior	1.47M/1.30M	Price	32.75
Gross Margin	60.36%	Profit Margin	-54.57%	Avg. Volume	446,783	Target Price	62.71
Oper. Margin	-37.97%	Earnings Date	May 6	Volume	311,432	Change	-1.27%

Healthcare | Medical Devices | United States

About RxSight, Inc.

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

RxSight, Inc. News

04/25/24	Should You Investigate RxSight, Inc. (NASDAQ:RXST) At US$52.84?
04/22/24	RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
04/04/24	RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
03/27/24	RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03/02/24	RxSight, Inc. (NASDAQ:RXST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$57.75
03/01/24	RxSight Full Year 2023 Earnings: EPS Beats Expectations
02/29/24	RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
02/29/24	RxSight, Inc. (NASDAQ:RXST) Q4 2023 Earnings Call Transcript
02/29/24	Q4 2023 Rxsight Inc Earnings Call
04:38 PM	RxSight Inc (RXST) Reports Significant Revenue Growth in Q4 and Full Year 2023
04:05 PM	RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
02/14/24	RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
01/21/24	With 64% institutional ownership, RxSight, Inc. (NASDAQ:RXST) is a favorite amongst the big guns
01/19/24	Director Shweta Maniar Sells 6,399 Shares of RxSight Inc
01/12/24	3 Stocks to Buy BEFORE They Become Household Names
01/12/24	Strength Seen in Integer (ITGR): Can Its 3.8% Jump Turn into More Strength?
01/09/24	RxSight, Inc. (RXST) Just Overtook the 20-Day Moving Average
01/07/24	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
12/27/23	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
11/15/23	RxSight, Inc. (RXST) Recently Broke Out Above the 50-Day Moving Average

RXST Chatroom

MaverikIT Posted - 4 days ago

@net0trader @Wigglyick @Im_not_Mr_Lebowski @DonCorleone77 @IsabellaDC @Cash4freedom @RonIsWrong $RXST ER 5/6

Doozio Posted - 5 days ago

$RXST may need moar chop chop. Bahhht still appears 🧠⏰.

Stock_Titan Posted - 5 days ago

$RXST RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024 https://www.stocktitan.net/news/RXST/rx-sight-inc-to-report-first-quarter-financial-results-on-may-6-2la3lzk1yal7.html

MaverikIT Posted - 2 weeks ago

@DonCorleone77 @net0trader @Wigglyick @IsabellaDC @Cash4freedom @RonIsWrong @Im_not_Mr_Lebowski $ALAR $RXST

MaverikIT Posted - 2 weeks ago

@net0trader @DonCorleone77 @Cash4freedom @Im_not_Mr_Lebowski @Wigglyick @IsabellaDC @RonIsWrong $RXST - can't keeping this down for long $STAA - sun shinny day$

erevnon Posted - 2 weeks ago

Needham reiterates RxSight $RXST at Buy and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

MaverikIT Posted - 2 weeks ago

@IsabellaDC @net0trader @DonCorleone77 @Cash4freedom @Im_not_Mr_Lebowski @RonIsWrong @Wigglyick $STAA - gonna be bright sun shinny day$ $RXST

DEXWireNews Posted - 3 weeks ago

RxSight (NASDAQ: $RXST) Soars 7%+ on Friday After Launch of Latest Light Adjustable Lens https://dexwirenews.com/rxsight-nasdaq-rxst-soars-7-on-friday-after-launch-of-latest-light-adjustable-lens/ #RxSight #NASDAQ #RXST #Healthcare #Stocks #MedicalDevices #Surgery #UVLight #IntraocularLense #Vision #Eyes #Sight #StocksToWatch #Investments

MaverikIT Posted - 3 weeks ago

@net0trader @RonIsWrong @Wigglyick @Cash4freedom @Im_not_Mr_Lebowski @IsabellaDC @DonCorleone77 $RXST

MaverikIT Posted - 3 weeks ago

@net0trader @RonIsWrong @Wigglyick @Cash4freedom @Im_not_Mr_Lebowski @IsabellaDC @DonCorleone77 $STAA - gonna be sun shinny day$ into da weekend $RXST

DEXWireNews Posted - 3 weeks ago

$RXST https://www.tradingview.com/chart/RXST/9LBOQZGR-RxSight-Unveils-Light-Adjustable-Lens-for-Cataract-Surgery/9LBOQZGR

MaverikIT Posted - 3 weeks ago

@RonIsWrong @IsabellaDC @DonCorleone77 @net0trader @Wigglyick @Im_not_Mr_Lebowski @Cash4freedom $RXST - continuation of new leg$ $STAA

DonCorleone77 Posted - 3 weeks ago

$RXST RxSight launches its newest light adjustable lens, the LAL+ RxSight announced the commercial launch of its newest Light Adjustable Lens, the LAL+. The company now offers two lenses in the Light Adjustable Lens platform: the LAL and the Light Adjustable Lens+, LAL+ . The LAL+ has a modified aspheric anterior surface that creates a small continuous increase in central lens power, which is designed to slightly extend the depth of focus. In addition, RxSight's Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens , RxSight Light Delivery Device and accessories, will be the subject of various doctor presentations at the annual meeting of the American Society of Cataract and Refractive Surgery, ASCRS, in Boston on April 5-8.

Stock_Titan Posted - 3 weeks ago

$RXST RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting https://www.stocktitan.net/news/RXST/rx-sight-announces-commercial-launch-of-its-newest-light-adjustable-4umjtd1tlena.html

MaverikIT Posted - 3 weeks ago

@DonCorleone77 @net0trader @Wigglyick @RonIsWrong @Im_not_Mr_Lebowski @IsabellaDC @Cash4freedom $RXST $STAA

InsiderPeek Posted - 3 weeks ago

$RXST CFO Thunen Shelley B sold 20k shares for $997.9k (ownership down 47.51%) insiderpeek.com/company/RXST

Stock_Titan Posted - 1 month ago

$RXST RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference https://www.stocktitan.net/news/RXST/rx-sight-inc-to-participate-in-the-23rd-annual-needham-virtual-nhpdsn5oyvwg.html

net0trader Posted - 1 month ago

@MaverikIT @Cash4freedom @Wigglyick @DonCorleone77 @Im_not_Mr_Lebowski @RonIsWrong @IsabellaDC loving this $rxst setup here

MaverikIT Posted - 1 month ago

@net0trader @Cash4freedom @RonIsWrong @Im_not_Mr_Lebowski @DonCorleone77 @Wigglyick @IsabellaDC $RXST - ready for next leg$

DailyStocksPicks Posted - 1 month ago

About Today's Oversold Stock#2... RxSight Inc. ($RXST): RxSight, a pioneer in post-cataract surgery eye care with its Light Adjustable Lens system, has seen a stock increase of 14.6% since the beginning of the year. Despite strong performance and analyst support, the stock price is perceived to lag behind its potential, suggesting a possible undervaluation or market oversight. $EYE, $STAA, $WRBY, $BHC For More Details: https://youtu.be/p1X3LZUnRrA

OPmoney Posted - 1 month ago

$RXST stuffing the channel Eye Docs fudging the numbers on weak/fail LAL outcomes see Jan 37pps Gap Fill DOWN while $STAA just gapped-UP off a 2-3 Month bottom

MaverikIT Posted - 1 month ago

@DonCorleone77 @net0trader @IsabellaDC @RonIsWrong @Wigglyick @Cash4freedom @Im_not_Mr_Lebowski $STAA - nice bright and sun shinny day $RXST

MaverikIT Posted - 1 month ago

@RonIsWrong @net0trader @IsabellaDC @DonCorleone77 @Wigglyick $RXST - wanting new leg$ $STAA

MaverikIT Posted - 1 month ago

@net0trader @IsabellaDC @RonIsWrong @DonCorleone77 @Wigglyick @Cash4freedom @Im_not_Mr_Lebowski $STAA - gonna be bright ssun shinny day $RXST

OPmoney Posted - 1 month ago

$RXST Pump'd to perfection

Quantumup Posted - 1 month ago

Morgan Stanley raised PT $RXST $65 was $36/Overweight~says shares have had a strong run since RxSight's earnings pre-announcement and they remain Bullish on the ability of the Light Adjustable Lens to take meaningful share and continue to beat Wall St #s. $eye $strr $wrby $bhc

MaverikIT Posted - 1 month ago

@net0trader @Im_not_Mr_Lebowski @Wigglyick @RonIsWrong @Cash4freedom @IsabellaDC $RXST +1.96 - gonna be 'bright sun shinny day" '

MaverikIT Posted - 1 month ago

@net0trader @Im_not_Mr_Lebowski @Wigglyick @RonIsWrong @Cash4freedom @IsabellaDC Grandpa/Grandma fav store $TSCO $DBCO $RXST

Stock_Titan Posted - 02/29/24

$RXST RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference https://www.stocktitan.net/news/RXST/rx-sight-inc-to-participate-in-the-34th-annual-oppenheimer-46plj2oxqfbr.html

Quantumup Posted - 02/29/24

Needham⬆️raised PT $RXST $64 was $53/Buy~after "4Q23 Showed Solid Rev Growth and Margin Improvement:" Given recent channel✅s, believes $RXST's platform is seeing meaningful adoption among the MD Cmty, which should cont 2drive💪🏽rev growth. GMI should cont in '24 w/ the rollout of a reconfig'd LDD/increasing LAL mix.

Analyst Ratings

Needham	Buy	Apr 11, 24
Stifel	Buy	Feb 29, 24
JP Morgan	Overweight	Feb 29, 24
Oppenheimer	Outperform	Feb 29, 24
Needham	Buy	Feb 29, 24
Stifel	Buy	Feb 12, 24
Oppenheimer	Outperform	Jan 29, 24
Oppenheimer	Outperform	Jan 16, 24
Oppenheimer	Outperform	Jan 8, 24

Insider Trades	Relationship	Date	Transactions	Cost($)	#Shares	Value($)	#Share Own	SEC Form 4
Thunen Shelley B	Chief Financial Offi.. Chief Financial Officer	Jan 26	Sell	47.11	31,772	1,496,779	6,791	01/29/24
Thunen Shelley B	Chief Financial Offi.. Chief Financial Officer	Jan 26	Option	9.71	36,272	352,201	38,563	01/29/24
Weinberg Eric	Chief Commercial Off.. Chief Commercial Officer	Jan 22	Sell	48.0006	10,000	480,006	309,978	01/22/24
Goldshleger Ilya	Chief Operating Offi.. Chief Operating Officer	Jan 22	Sell	48	5,000	240,000	26,475	01/22/24
Goldshleger Ilya	Chief Operating Offi.. Chief Operating Officer	Jan 22	Option	18.9	5,000	94,500	31,475	01/22/24
Goldshleger Ilya	Chief Operating Offi.. Chief Operating Officer	Jan 09	Sell	47	5,000	235,000	26,475	01/10/24
Goldshleger Ilya	Chief Operating Offi.. Chief Operating Officer	Jan 09	Option	18.9	5,000	94,500	31,475	01/10/24
Weinberg Eric	Chief Commercial Off.. Chief Commercial Officer	Jan 09	Sell	46.00	10,000	460,000	319,978	01/10/24
Kurtz Ronald M MD	President & CEO President & CEO	Dec 27	Sell	41.0888	22,500	924,498	867,110	12/29/23
Goldshleger Ilya	Chief Operating Offi.. Chief Operating Officer	Dec 18	Sell	39.12	10,937	427,855	26,475	12/20/23
Goldshleger Ilya	Chief Operating Offi.. Chief Operating Officer	Dec 18	Option	9.61	10,937	105,105	37,412	12/20/23
Weinberg Eric	Chief Commercial Off.. Chief Commercial Officer	Dec 15	Sell	40.0127	8,715	348,711	341,263	12/19/23
Thunen Shelley B	Chief Financial Offi.. Chief Financial Officer	Dec 15	Sell	39.33	40,000	1,573,200	28,402	12/18/23
Thunen Shelley B	Chief Financial Offi.. Chief Financial Officer	Dec 15	Option	15.6	20,000	312,000	22,291	12/18/23
Corley Jesse Anderson	Director Director	Dec 14	Sell	40.12	12,000	481,440	13,625	12/18/23
Kurtz Ronald M MD	President & CEO President & CEO	Dec 14	Sell	39.7	40,000	1,588,000	889,610	12/18/23
Tammenoms Bakker Juliet	Director Director	Nov 28	Sell	29.7	494,313	14,681,096		11/30/23
Tammenoms Bakker Juliet	Director Director	Nov 14	Sell	27.16	500,000	13,580,000	494,313	11/16/23
Tammenoms Bakker Juliet	Director Director	Sep 07	Sell	30.12	32,950	992,454	20,223	09/11/23
Maniar Shweta	Director Director	Aug 29	Sell	28.064	4,292	120,451	24,947	08/29/23
Tammenoms Bakker Juliet	Director Director	Aug 24	Sell	29.25	16,208	474,084	53,173	08/28/23
Goldshleger Ilya	Chief Operating Offi.. Chief Operating Officer	Jul 26	Option	3.9254	25,475	100,000	26,475	07/27/23
Tammenoms Bakker Juliet	Director Director	Feb 10	Buy	12.50	480,000	6,000,000	980,000	02/13/23